Furthermore, when people travel to countries or areas where climate-driven malaria cases are on the rise, there is a greater possibility of bringing those infections back to the U.S., where local mosquitoes could be exposed to the parasite in an infected person's blood.
The Bill & Melinda Gates Medical Research Institute has multiple tuberculosis (TB) therapies and a prophylactic vaccine in development, and its chief medical officer, Michael W. Dunne, MD, remains optimistic long-term about the state of clinical care, especially in low-and-middle-income countries.